Related Experiment Videos
Local anesthetics in pediatric anesthesia: an update
1Department of Anesthesiology, Critical Care and Surgery, Pontchaillou Hospital, University of Rennes 1, Rennes, France.
Minerva Anestesiologica
|May 12, 2005
Summary
Newer local anesthetics like ropivacaine and levobupivacaine offer potentially safer alternatives to bupivacaine for pediatric analgesia. This review examines their metabolism, selection criteria, and safe use.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Bupivacaine has been the preferred local anesthetic in pediatrics for decades.
- Newer agents, ropivacaine and levobupivacaine, are presumed safer due to reduced cardiotoxicity and neurotoxicity.
- These newer anesthetics challenge bupivacaine's status for long-lasting pain relief.
Purpose of the Study:
- To review the metabolism of ropivacaine and levobupivacaine.
- To outline the criteria for selecting these newer local anesthetics.
- To summarize the safety profiles and appropriate use of ropivacaine and levobupivacaine.
Main Methods:
- Literature review of existing studies on bupivacaine, ropivacaine, and levobupivacaine.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Synthesis of clinical guidelines and safety reports.
Main Results:
- Ropivacaine and levobupivacaine exhibit distinct metabolic pathways and elimination profiles compared to bupivacaine.
- Specific patient factors and procedural requirements guide the choice between these local anesthetics.
- Current evidence suggests a favorable safety profile for ropivacaine and levobupivacaine in pediatric populations.
Conclusions:
- Ropivacaine and levobupivacaine represent valuable alternatives to bupivacaine in pediatric anesthesia.
- Careful consideration of metabolism, efficacy, and safety is crucial for optimal agent selection.
- Further research may refine the understanding of long-term safety and efficacy in diverse pediatric groups.